GRACEcast Lung Cancer Video podcast

Player FM - Internet Radio Done Right

22 subscribers

Health and Well-Being Videos

Menambahkan nine tahun yang lalu

Konten disediakan oleh cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/species-unite">Species Unite</a></span>

1
Species Unite

Berhenti berlangganan

4 hari yang lalu4d ago

Berhenti berlangganan

Bulanan+

Stories that change the way the world treats animals.

GRACEcast Lung Cancer Video

Beranda serial•Feed

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

301 episode

#Science #Grace #Cancergrace #Lung #Cancer #Nsclc #Chemotherapy #Chemo #Radiation #Non #Small #Cell #cancerGRACE - H. Jack West, MD #Health and Well-Being #Video #Podcasting Education #Medicine #cancerGRACE - H. Jack West

GRACEcast Lung Cancer Video

22 subscribers

updated 11 tahun yang lalu

Beranda serial•Feed

301 episode

Semua episode

GRACEcast Lung Cancer Video

1
Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy? 4:36

11 years yang lalu4:36

Putar Nanti

Daftar

Suka

Menyukai

4:36

Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.

GRACEcast Lung Cancer Video

1
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation? 5:28

11 years yang lalu5:28

5:28

The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.

GRACEcast Lung Cancer Video

1
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? 2:27

11 years yang lalu2:27

2:27

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

GRACEcast Lung Cancer Video

1
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment? 7:28

11 years yang lalu7:28

7:28

The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.

GRACEcast Lung Cancer Video

1
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope 7:22

11 years yang lalu7:22

7:22

The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.

GRACEcast Lung Cancer Video

1
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer 3:52

11 years yang lalu3:52

3:52

"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).

GRACEcast Lung Cancer Video

1
MET-Amplified Lung Cancer: A New Target for XALKORI? 7:18

11 years yang lalu7:18

7:18

Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.

GRACEcast Lung Cancer Video

1
CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer 4:10

11 years yang lalu4:10

4:10

Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.

GRACEcast Lung Cancer Video

1
FGFR and Its Role in Treating Squamous Cell Lung Cancer 2:21

11 years yang lalu2:21

2:21

Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.

GRACEcast Lung Cancer Video

1
AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer 11:36

11 years yang lalu11:36

11:36

EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.

GRACEcast Lung Cancer Video

1
What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer? 2:17

11 years yang lalu2:17

2:17

"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.

GRACEcast Lung Cancer Video

1
The Promise of Immunotherapy in Lung Cancer 1:21

11 years yang lalu1:21

1:21

Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.

GRACEcast Lung Cancer Video

1
Does Gilotrif Help EGFR Positive Lung Cancer Patients? 8:16

11 years yang lalu8:16

8:16

An analysis of two large studies of EGFR lung cancer patients tried to determine if Gilotrif helped patients live longer.

GRACEcast Lung Cancer Video

1
Is Progression-Free Survival Meaningful? 3:25

11 years yang lalu3:25

3:25

Progression-free survival is something that doctors measure to determine how well a patient responds to a particular treatment. But does it translate to increased overall survival?

GRACEcast Lung Cancer Video

1
DDR2 Mutations in Squamous Cell Lung Cancer 1:07

11 years yang lalu1:07

1:07

A genetic mutation and a leukemia drug may provide new hope for patients with squamous cell lung cancer patients.

GRACEcast Lung Cancer Video

1
Does Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients? 9:26

11 years yang lalu9:26

9:26

Drs. Nasser Hanna, Melissa Johnson and Jack West discuss results of a phase 2 trial presented at ASCO 2014 that studied if adding Avastin (bevicizumab) to Tarceva helped EGFR positive lung cancer patients increase progression-free survival. June 2014.

GRACEcast Lung Cancer Video

1
What is FGFR, and Could It Be a Valuable Target for Patients with Lung Cancer? 3:50

11 years yang lalu3:50

3:50

Dr. Joel Neal of Stanford University Medical Center talks about FGFR - fibroblast growth factor receptor - and how it can impact non-small cell lung cancer growth.

GRACEcast Lung Cancer Video

1
How Do We Make EGFR Inhibitors Work Better for Patients 3:15

11 years yang lalu3:15

3:15

Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute describes what research indicates may be more successful treatments for EGFR lung cancer patients.

GRACEcast Lung Cancer Video

1
TH 302: New Drug May Make Tumors Less Resistant to Treatment 1:26

11 years yang lalu1:26

1:26

Dr. Jonathan Goldman discusses a drug currently being studied that may make lung cancer tumors more susceptible to treatment. February 2014.

GRACEcast Lung Cancer Video

1
Should We Do Broad Sequencing of All Lung Tumors? 3:21

11 years yang lalu3:21

3:21

How much detail is needed when determining how to treat lung cancer? Should patients be tested for all the mutations that may exist within their tumors? Dr. Jonathan Riess discusses this issue and how he makes decisions regarding his own patients.

GRACEcast Lung Cancer Video

1
How Do the New ALK Inhibitor Drugs Compare to Xalkori (Crizotinib) for ALK+ Lung Cancer Patients? 4:58

11 years yang lalu4:58

4:58

Xalkori (crizotinib) has had great success treating ALK positive lung cancer patients. The next generation of ALK inhibitors are also showing great promise. In this video, Dr. Leena Gandhi of Dana-Farber Cancer Institute talks about the research.

GRACEcast Lung Cancer Video

1
Why Are Non-Mutated EGFR Genes Called "Wild Type?" 1:21

11 years yang lalu1:21

1:21

When it comes to EGFR and lung cancer, is a mutation good or bad? Dr. Joel Neal of Stanford University Medical Center explains why non-mutated genes are called "wild type." February 2014.

GRACEcast Lung Cancer Video

1
Teaching the Immune System to Attack Lung Cancer Tumors 6:18

11 years yang lalu6:18

6:18

Immune therapy, or immunotherapy, is one of the most exciting areas of lung cancer research. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center explains how immune therapy works and how it might impact the future of lung cancer treatment.

GRACEcast Lung Cancer Video

1
Advice for Lung Cancer Patients: Know Thy Cancer 1:32

11 years yang lalu1:32

1:32

What should lung cancer patients know about their disease? Dr. Jonathan Riess argues that patients should understand what type of lung cancer they have and which, if any, mutations their lung tumors may have. He explains why in this video.

GRACEcast Lung Cancer Video

1
Is It Necessary for Early Stage Lung Cancer Patients to Get Molecular Testing for Their Tumors? 1:56

11 years yang lalu1:56

1:56

If you were diagnosed with early stage lung cancer, should you receive molecular testing on your tumor in order to get targeted therapy? Dr. Joel Neal of Stanford University Medical Center discusses the reasons for and against it. February 2014.

GRACEcast Lung Cancer Video

1
Treating EGFR Patients After Tarceva Stops Working 2:47

11 years yang lalu2:47

2:47

Tarceva (erlotinib) has greatly helped EGFR positive lung cancer patients, but eventually it stops working. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center talks about the next generation EGFR inhibitors that may soon become available. February 2014.

GRACEcast Lung Cancer Video

1
Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive Non-small Cell Lung Cancer? 1:43

11 years yang lalu1:43

1:43

Dr. Joel Neal of Stanford University Medical Center discusses the SELECT clinical trial which studied early stage non-small cell lung cancer patients and whether or not Tarceva (erlotinib) would prevent disease recurrence. February 2014.

GRACEcast Lung Cancer Video

1
An Update on ECOG 1505: Will Avastin (Bevacizumab) Become Standard Treatment for Early Stage Lung Cancer Patients? 3:55

11 years yang lalu3:55

3:55

Dr. Heather Wakelee of Stanford University Medical Center talks about how studies looking into Avastin (bevacizumab) for early stage lung cancer patients are progressing. February 2014.

GRACEcast Lung Cancer Video

1
Targeted Treatment for Lung Cancer After Progression 4:48

11 years yang lalu4:48

4:48

Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute discusses whether or not patients on targeted therapies, such as EGFR inhibitors, should stay on those therapies after their cancers begin to grow again. February 2014.

GRACEcast Lung Cancer Video

1
Can Vaccines Fight Lung Cancer? 2:25

11 years yang lalu2:25

2:25

Dr. Charles Rudin of Memorial Sloan Kettering on the possibility of using vaccines to fight lung cancer. February 2014.

GRACEcast Lung Cancer Video

1
CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients 2:27

11 years yang lalu2:27

2:27

Dr. Heather Wakelee of Stanford University Medical Center talks about a drug still in development for EGFR lung cancer patients, CO-1686. February 2014.

GRACEcast Lung Cancer Video

1
Why Do We Call Them "Small Cell Lung Cancer" and "Non-Small Cell Lung Cancer"? 1:04

11 years yang lalu1:04

1:04

Dr. Cathy Pietanza of Memorial Sloan Kettering explains how small cell lung cancer and non-small cell lung cancer are differentiated. February 2014.

GRACEcast Lung Cancer Video

1
Targeting the RAF Pathway in Lung Cancer 4:20

11 years yang lalu4:20

4:20

Dr. Charles Rudin of Memorial Sloan Kettering talks about RAF and other genetic mutations that play a role in the growth of lung cancer. February 2014.

GRACEcast Lung Cancer Video

1
Is It Possible to Test Lung Tumors Without Doing a Biopsy? 4:00

11 years yang lalu4:00

4:00

Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute talks about exciting new developments which will allow oncologists to test patients' lung tumors without invasive biopsies. February 2014.

GRACEcast Lung Cancer Video

1
What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer? 2:54

11 years yang lalu2:54

2:54

Dr. Charles Rudin of Memorial Sloan Kettering on how PARP inhibitors may benefit patients with small cell lung cancer. February 2014.

GRACEcast Lung Cancer Video

1
New Insights into Small Cell Lung Cancer 1:36

11 years yang lalu1:36

1:36

Dr. Cathy Pietanza of Memorial Sloan Kettering on the new avenues of research into the treatment of small cell lung cancer. February 2014.

GRACEcast Lung Cancer Video

1
In What Clinical Setting Should Immunotherapies Be Developed? 2:08

11 years yang lalu2:08

2:08

Dr. Charles Rudin of Memorial Sloan Kettering discusses immune therapies that show promise in fighting lung cancer. February 2014.

GRACEcast Lung Cancer Video

1
Maintenance Therapy in Small Cell Lung Cancer 1:53

11 years yang lalu1:53

1:53

Dr. Cathy Pietanza of Memorial Sloan Kettering on current and emerging treatments that are given to help keep small cell lung cancer from coming back after it has disappeared following initial therapy. February 2014.

GRACEcast Lung Cancer Video

1
LDE225 and Small Cell Lung Cancer 1:18

11 years yang lalu1:18

1:18

Dr. Cathy Pietanza of Memorial Sloan Kettering talks about a drug currently in clinical trials that may successfully treat small cell lung cancer. February 2014.

GRACEcast Lung Cancer Video

1
Is There a Silver Bullet for Small Cell Lung Cancer? 1:51

11 years yang lalu1:51

1:51

Dr. Cathy Pietanza of Memorial Sloan Kettering discusses potential areas of success in the treatment of small cell lung cancer. February 2014.

GRACEcast Lung Cancer Video

1
Advice for Newly Diagnosed Small Cell Lung Cancer Patients 1:16

11 years yang lalu1:16

1:16

Dr. Cathy Pietanza of Memorial Sloan Kettering offers suggestions for newly diagnosed small cell lung cancer patients. February 2014.

GRACEcast Lung Cancer Video

1
PARP Inhibitors in Small Cell Lung Cancer 1:23

11 years yang lalu1:23

1:23

Dr. Cathy Pietanza of Memorial Sloan Kettering talks about the role of PARP inhibitors in the treatment of small cell lung cancer. February 2014.

GRACEcast Lung Cancer Video

1
What's the Status and Potential Utility of Cabozantinib in Lung Cancer? 3:22

11 years yang lalu3:22

3:22

Dr. Heather Wakelee of Stanford University Medical Center discusses whether or not cabozantinib - a drug already approved for thyroid cancer - can help patients with lung cancer. February 2014.

GRACEcast Lung Cancer Video

1
MK-3475 and its Efficacy in Lung Cancer 4:54

11 years yang lalu4:54

4:54

Dr. Edward Garon discusses what researchers are learning about MK-3475, an immune therapy treatment currently in clinical trial. February 2014.

GRACEcast Lung Cancer Video

1
How Do the Different Immune Checkpoint Inhibitors in Lung Cancer Compare? 2:50

11 years yang lalu2:50

2:50

Dr. Edward Garon warns that it is still too early to compare which immune therapies will be more effective in treating lung cancer.February 2014.

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.